NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation by unknown
NF-gB and Ir~B~: An Inducible Regulatory System 
in Endothelial Activation 
By Margaret A. Read, Maryann Z. Whitley, Amy J. Williams, 
and Tucker Collins 
From the Vascular Research Division, Department of Patholog2?, Brigham and Women's Hospital 
and Harvard Medical School, Boston, Massachusetts 02115 
Summary 
Structural analysis of the promoters of several endothelial genes induced at sites of inflammatory 
or immune responses reveals binding sites for the transcription factor nuclear factor KB (NF-KB). 
Endothelial cells express transcripts encoding the pS0/p105 and p65 components of NF-IcB and 
the tel-related proto-oncogene c-re/; steady state levels of these transcripts are transiently increased 
by tumor necrosis factor ce (TNF-ce).  Western blotting revealed that stimulation of endothelial 
calls with TNF-ce resulted in nuclear accumulation of the p50 and p65 components of NF-KB. 
Ultraviolet crosslinking and immunoprecipitation demonstrated binding of the p50 and p65 
components of NF-KB to the E-selectin xB site. Endothelial cells express an inhibitor of NF-gB 
activation, IgB-ce (MAD-3). Protein levels of this inhibitor fall rapidly after TNF-cx stimulation. 
In parallel,  p50 and p65 accumulate in the nucleus and RNA transcript levels for IgB-o~ are 
dramatically upreguhted. Recombinant p65 stimulates expression of E-sdectin promoter-reporter 
constructs. IKB-ce  inhibits p65 or TNF-ce-stimulated E-sdectin promoter-reporter gene expression 
in transfected  endothelial cells. The NF-gB and IKB-ce system may be an inducible regulatory 
mechanism in endothelial activation. 
A  sites of inflammation and cell-mediated immune re- 
sponses, endothelial cells develop a characteristic  mor- 
phology and synthesize new proteins not present in resting 
vascular beds. These alterations in endothelial cell function 
are part of a process termed endothelial activation (for a re- 
view see reference 1). Many of these morphologic and func- 
tional changes can be induced in cultured endothelial cells 
by purified immune mediators,  such as monokines, lym- 
pbokines, and bacterial LPS. Based on these in vitro studies, 
it has been proposed that resident tissue cells and infiltrating 
lenkocytes release cytokines during inflammatory and immune 
responses  that cause endothelial cells to become activated. 
The activated endothelial cells express new surface proteins 
and soluble mediators that subsequently recruit additional 
circulating cells to the peripheral tissues. Many inducible genes 
involved in endothelial activation, including vascular cell adhe- 
sion molecule 1 (2, 3), E-selectin (4, 5), tissue factor (6), IL-1 
(7), IL-6 (8), G-CSF (9),  IL-8 (10) and c-rayc  (11), contain 
elements in their promoter regions that could be recognized 
by the nuclear factor xB (NF-gB)I/Rel family of transcrip- 
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tion factors. With some of these genes, deletion analysis has 
demonstrated that the NF-KB sites are functional elements 
in cytokine or LPS-induced endothelial expression (2-4). 
NF-xB  is  a  transcription factor associated  with  rapid- 
response activation mechanisms (for reviews see references 
12-15). The NF-KB protein subunits, pS0 (NFKB1, derived 
from its p105 precursor) and p65 (Rd A), belong to the Rel 
fam~y of genes that also includes p52 (NFKB2 and its pl00 
precursor, also called lyt-10), the v-,el oncogene, c-tel protoon- 
cogene products, and the Drosophila morphogen dorsal.  In 
resting cells, NF-xB binding proteins are in an inactive cyto- 
solic form and are complexed to members of a family of in- 
hibitory proteins referred to as IKB. Several IxB proteins have 
been cloned or purified including bcB-c~ (MAD3), IKB-~, 
p105, IKB-3, and bcl-3 (for reviews see references 12, 15). All 
IxB forms identified to date contain multiple ankyrin repeats, 
which are involved in interactions with NF-KB. NF-gB can 
be activated by a number of diverse agents, such as the cytokines 
IL-I~ and TNF-c~, LPS, oxidative stress and viral products. 
These agents initiate the nuclear translocation and subsequent 
DNA  binding  of  NF-KB, possibly  by  posttranslational 
modifications that result in loss of inhibition by IKB proteins 
(12-15). One of these inhibitors, IgB-c~, binds the p65 subunit 
preferentially and is released from p65 after phosphorylation 
in response to mediators which activate NF-~B (16-19). The 
existence of multiple Rel family members and I~B subunits 
emphasizes the need to examine the structure and regulation 
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A growing body of evidence suggests that the NF-KB/IgB 
system might play a regulatory role in endothelial activation 
(for a review see reference  20).  NF-gB can be activated by 
a number of stimuli relevant  to endothelial activation, and 
functional NF-gB sites are found in many genes whose ex- 
pression is increased  at sites of inflammatory responses.  In 
support of this proposal, it has been reported that cytokine 
or LPS activation induces NF-gB-like DNA-binding activity 
in endothelial cells (e.g.,  2-5,  21). However, these studies 
do not establish  the repertoire of Rel family members ex- 
pressed by endothelial cells, the identity of the family members 
involved in gB complex formation, or the role of IgB in 
regulating NF-gB activation in endothelial ceils. Here we 
define the dynamic pattern of expression of the Rel proteins 
expressed by endothelial ceUs in response to TNF-o~ stimula- 
tion and show that specific members of the family are func- 
tionally important in the cytokine-induced expression  of a 
leukocyte adhesion molecule, E-select-in. Furthermore, we pro- 
vide evidence  for a rapid loss of IgB-ol in endothelial cells 
stimulated with the TNF-c~.  The time course of this loss 
correlates  with the appearance  of nuclear p50 and p65,  as 
well as NF-gB binding activity. IgB-ol is rapidly resynthe- 
sized after the loss, suggesting an autoregulatory mechanism 
for NF-gB regulation in endothelium. 
Materials and Methods 
Cell Cultures.  Human endothelial cells obtained from collage- 
nase-digested  umbilical  veins (22) were cultured in M199 with 20% 
fetal bovine serum (FBS), 100 #g/m1 porcine intestinal heparin, 
50 #g/ml endothelial mitogen, 50 U/ml penicillin and 50 #g/ml 
streptomycin,  and 25 mM Hepes in gehtin-coated plates. Confluent 
monolayers (3-5  x  106  cells, passages 2-4)  were exposed to 
recombinant human TNF-c~ (Genentech, San Francisco, CA) at 
a final concentration of 100 or 200 U/ml in complete media. Bo- 
vine aortic endothelial cells (BAEC) were isohted and maintained 
in culture using modifications  of  previously  described  procedures (2). 
Northern Analysis.  Total  RNA from 107 cells was isolated by 
the guanidine isothiocyanate  method (23). RNA was separated  by 
electrophoresis on a 1% agarose formaldehyde  gel, transferred to 
Hybond-N membrane (Amersham  Corp., Arlington Heights, IL), 
and immobilized by UV irradiation with a UV StratalLnker  2400 
(Stratagene, La Jolla, CA). Blots were prehybridized for 6 h and 
hybridized overnight (24) at 42~  with 3Zp-labeled  probes (Mega- 
prime kit; Amersham Corp.). eDNA clones for p65, p50/p105, 
c-Rel, and IKB-c~ were generously provided by Michael Lenardo 
(National Institute of Allergy and Infectious Diseases, National 
Institutes of Health, Bethesda,  MD), Gary Nabel (Howard Hughes 
Medical Institute,  University of Michigan Medical Center, Ann 
Arbor, MI), and Stephen Haskill (University of North Carolina, 
Chapd Hill, NC). 
CellExtmcts.  After experimental  treatment of  endothelial  cells, 
nuclear and cytosolic  extracts were prepared as described  by Moliter 
et al. (25) with the following modifications. Cell monohyers (3-5 
x  10  e cells) were harvested by scraping, washed in cold PBS, and 
incubated in 100 #1 of buffer A (10 mM Hepes, pH 8.0, 1.5 mM 
MgClz, 10 mM KC1, 0.5 mM dithiothreitol (DTT), 200 mM su- 
crose, 0.5 mM PMSF, 1 #g/m1 leupeptin, 1 #g/ml aprotinin, and 
0.5% NP-40) for 10 min at 4~  The crude nudei released by lysis 
were collected by microcentrifugation and the cytosolic extracts 
frozen on dry ice. The nuclear pellet was rinsed once in buffer A 
and resuspended in 100/zl of buffer B (20 mM Hepes, pH 8.0, 
20% glycerol, 0.1 M KC1, 0.2 mM EDTA, 0.5 mM PMSF, 0.5 
mM DTT, and 1 #g/ml each lenpeptin and aprotinin). Nuclei were 
sonicated for 10 s at 15% power output (Virsonic Cell Disruptor; 
Virtis, Gardner, NY) and clarified  by microcentrifugation for 30 s. 
The resulting supernatants contained 1-2 mg/ml protein by Brad- 
ford assay (26) with BSA as the standard. Nuclear extracts were 
frozen on dry ice and stored at  -80~ 
Electrophoretic Mobility Shift Assay (EMSA).  A double-stranded 
oligonucleotide  containing the E-sdectin NF-xB site (5'-AGCTTA- 
GAGGGGATTTCCGAGAGGA-Y)  was end-labeled  with cr 
ATP (50 #Ci at 3,000 Ci/mmol, New England Nuclear, Boston, 
MA) and the Klenow fragment ofEscherichia coli DNA polymerase 
I. Binding reactions in 20 #1 contained 15 #g nuclear extract pro- 
tein, binding buffer (10 mM Tris, pH 7.5, 20 mM NaC1, 1 mM 
DTT, 1 mM EDTA, 5% glycerol, 1 #g poly dI-dC, 1 #g single- 
stranded salmon testes DNA), and 100,000 cpm 321Mabeled DNA. 
Reactions were incubated at room temperature for 20 rain and ana- 
lyzed by electrophoresis on a 4% nondenaturing polyacrylamide 
gel at 180 V for 2 h using the high ionic strength conditions de- 
scribed by Ausubel  et al. (24). After electrophoresis, gels were dried 
and DNA-protein complexes  localized  by autoradiugraphy  for 18 h. 
Competition studies were performed by adding unlabeled double- 
stranded oligonucleotides  to the binding reaction  before the addition 
of labeled oligonucleotide. Competitor oligonucleotides included 
the wild-type NF-~B sequence (specified  above), and an NF-KB 5' 
mutant (5'-AGCTTAGATTTTATTTCCGAGAGGA-3').  Compe- 
tition reactions were incubated for 10 min before addition of la- 
beled oligonucleotide.  For supershift analysis,  nuclear extracts from 
TNF-cc-treated endothelial cells were incubated with 2 #1 of an- 
tisera or nonimmune rabbit serum for 15 min at room temperature 
before addition of binding buffer containing labeled oligonucleo- 
tide. Samples  were subjected to electrophoresis as described above. 
Antibodies to NF-r,B and lr,  B Proteins.  Peptide-specific  rabbit an- 
tisera to p65, pS0, and c-Rel were generously provided by Warner 
Greene (Gladstone  Institute of  Virology and Immunology, Univer- 
sity of  Califoruia, San Francisco, CA) (27). Anti-IKB-c~  was gener- 
ously provided by Stephen Haskill (16, 28). 
UV-CrosslinkingandlmmunoFrecipitation.  Photoreactive  labeled 
DNA probes were prepared by annealing coding strand temphte 
(5'-AGCTTAGA~ATTI~CGAGAGGA-Y) with a comple- 
mentary 10-base primer, (5'-TCCTCTCGGA-Y) and filling  in with 
the Klenow fragment of DNA polymerase I in the presence of 
a-[3zP]dATP, a-[~zP]dCTP, dGTP and 1:1 dTTP and 5-bromo-2'- 
~dine  5' triphosphate  (BrdU; Sigma  Chemical  Co., St. Louis, 
MO) (29). DNA binding reactions performed in 20 #1 as described 
above but using the BrdU substituted probe, were UV irradiated 
for 15 min using a transilhminator  (Fotodyae Inc., New Berlin, 
WI). For immunoprecipitation, radiolabeled  adducts were diluted 
in 180 #1 ELB buffer (50 mM Hepes-CI, pH 7.9, 250 mM NaC1, 
0.1% NP-40, 5.0 mM ED~, 0.5 mM DTT, and supplemented 
with 200 #g/m1 BSA, as well as 1 mM PMSF and I #g/ml each 
of leupeptin and aprotinin) and incubated with 1 #1 antisera (1 h 
on ice) followed by 20 #1 protein A-Sepharose (1 h on ice). Im- 
mune complexes were washed three times with ELB buffer and 
analyzed on 8% SDS-polyacrylamide  gels. 
Western Blot  Analysis.  Nuclear  and  cytosolic extracts from 
cytokine-treated human umbilical vein endothelial cells were elec- 
trophoresed on 8% SDS polyacrylamide gels and transferred to 
nitrocellulose in 25 mM Tris, 192 mM glycine, 5% methanol at 
504  NF-r.B/IgB-ot  and Endothelial  Activation 100 V for 1.5 h at 4~  Western blots were analyzed for p50, p65, 
c-gel, and I~B-c~ using antiserum at a 1:10,000, 1:10,000, 1:10,000, 
and 1:5000 dilution,  respectively. Immunoreactive proteins were 
detected according to the enhanced chemiluminescence protocol 
(Amersham) using 1:10,000 horseradish peroxidase-linked  donkey 
anti-rabbit  secondary antiserum. Blots were exposed to film for 
1-15 rain. 
E-Selectin Promoter Growth Hormone Receptor Constructs and Ex- 
pression Constructs.  An E-selectin promoter  fragment  (30) was 
generated by PCP, amplification and cloned into pOGH (Nichols 
Institute Diagnostics, San  Juan Capistrano, CA) to obtain an E-selec- 
tin-GH hybrid reporter construct.  The 613-bp PCK fragment 
(-578 to  +35) was gel purified, treated with Klenow to assure 
blunt ends, phosphorylated by polynucleotide kinase and blunt- 
end ligated into XbaI-cut and end-filled  pOGH. The internal dele- 
tion construct, pGH(-578)AKB  was made using two rounds of 
PCR amplification. Briefly, subfragments were generated corre- 
sponding to -578 to -100 and  -75 to +35 which included the 
SalI sites  at the - 100 and - 75 ends. The subfragments  were digested 
with Sall, Ligated  overnight, and used as the template for a second 
round of amplification  with forward - 578 and reverse + 35 primers. 
The product of the second amplification was cloned into Xba-l- 
digested pOGH as above. The DNA sequences of the promoter- 
reporter  constructs  were confirmed  by  dideoxynudeotide  se- 
quencing. To generate expression vectors, Nod fragments of p65 
and p105/p50 were cloned  into the NotI site ofpcDNA (Invitrogen, 
San Diego, CA). An EcoRI restriction fragment containing the 
complete open reading frame of bcB-c~ was cloned into the EcolLI 
site of pcDNA. 
DNA Sequencing.  Nucleotide sequence  was determined by the 
dideoxynucleotide chain termination method with modified T-7 
polymerase (United  States Biochemical, Cleveland, OH)  and 
c~-[3sS]dATP (New  England Nuclear).  Oligonucleotide primers 
were synthesized on a oligonucleotide synthesizer (model 381A; 
Applied Biosystems,  Foster  City, CA) and used without purifi~:ation. 
Transfection of Vascular Cells and Transient Expression of Chimeric 
Constructs.  Subconfluent human umbilical vein endothelial cul- 
tures (106 ceUs/100-mm culture dish) and bovine aortic endothelial 
cells were transfected by a modified calcium phosphate precipita- 
tion technique (23).  1 h  before transfection, M199 media was 
replaced with DMEM supplemented with 10% FBS, penicillin- 
streptomycin, and L-glutamine.  Cells were transfected  with 20 #g 
of  reporter phsmid and 0.5-1.0 #g p50 or p65 expression phsmids. 
All plates were balanced for total amount of DNA with an inert 
pBS vector. Relative transfection efficiency was determined by 
cotransfection with 5 #g pCATcontrol (Promega, Madison, WI). 
Bovine aortic endothelial  cells  were transfected  with 10 #g of  Is~B-ot 
expression phsmid,  10 #g reporter plasmid, and 2.5 #g of PDGF 
B chain promoter-CAT  vector (31). After tranffection,  cultures were 
washed twice with HBSS. Complete endothelial  media and TNF-c~ 
were added 2 h hter. 48 h after washing, samples of the medium 
were collected and assayed for growth hormone by using a com- 
me~.afiy  available  P,  IA kit (Nichols Institute Diagnostics, Geneva, 
Switzerland). Cells were harvested by trypsin dissociation, cen- 
trifuged (650 g for 5 min), washed once in PBS, and resuspended 
in 0.10 rnl of 0.25 M Tris-HC1 (pH 7.8) with 10 ~g/ml aprotinin 
(Sigma  Chemical  Co.). Calls  were lysed  by sonication  and one fieeze- 
thaw cycle.  Supernatants containing the cell extracts were obtained 
after centrifugation for 10 min at 14,000g and stored at -20"C. 
Transfection  of the E-selectin  promoter-GH reporter constructs was 
performed in duplicate for each experiment and the experiments 
were repeated at least three times using at least two independent 
plasmid preparations. Bach experiment included a negative con- 
trol,  the promoterless plasmid, pOGH, and a positive control, 
pTKGH. 
Conversion  of  radiohbded acetyl-coenzyme  A to acetylated  chlor- 
amphenicol was assayed  by the two phase fluor diffusion technique 
(23). For each sample, 30-50 #1 of cell extract was incubated at 
65~  for 15 min to inactivate  endogenous transacetyhses.  The assay 
was performed in a reaction mixture of 1.25 mM chloramphenicol 
(Sigma Chemical Co.), 125 raM Tris-HC1, pH 7.8, and 0.1 #Ci 
of [3H]-acetyl  coenzyme A (New England Nuclear) in a reaction 
volume of 0.2 ml. The reaction mixture was overlaid with 5 ml 
of water immiscible scintillation fluid (Econofluor; Dupont, Wil- 
mington, DE) and incubated at 37~  for 2 h. The activity of the 
[3H]-acetylated  chloramphenicol  was measured  on a geckbeta scin- 
tillation counter (LICK Piscataway, NJ). 
Results 
Cytokine-induced Expression of  NF-/cB ~anscripts in Cultured 
Endothelial Cellz  Fig. 1 shows Northern blot analysis  ofP,  NA 
from endothelial cells activated by TNF-c~. Transcript levels 
from two NF-~cB-dependent  leukocyte adhesion molecules, 
E-selectin and VCAM-1, are shown for comparison (Fig.  1 
A). p65 mRNA (2.6 kb [32]) was present constitutively and 
increased  slightly after cytokine activation, p105/pS0  tran- 
Figure 1.  Expression  of Rel family  members  by TlqF-ot-activated  en- 
dothdial cells. Human  umbilical  vein  endothelial  cells were incubated  in 
medium  alone  or treated  with TNF-o~  (200 U/ml) for the times  indicated. 
Total R~A was isolated and Northern blots prepared as described in 
Materials and Methods. (Risht) Transcript sizes (kb). 
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increased at 3 h, and gradually returned to basal levels. The 
two transcripts for c-Rd, >10.5 and 3.5 kb (35) were present 
in control cultured endothelial cells (Fig. 1 B). Levels  of both 
transcripts increased transiently in parallel after TNF-c~ stim- 
ulation and then decreased to bdow control levels kB-oe tran- 
script (28) levels increased dramatically in response to TNF-(a 
and remained elevated (Fig.  1 C). Thus, TNF-c~ activation 
of endothelial ceils caused a significant but transient increase 
in p65, p105/p50, and c-Rel, as well as a rapid increase in 
the transcript levels of a potential inhibitor of NF-r,B, IKB-ol. 
NF-rdt Binding to the E-selectin gB Site in Cuhured Endothelial 
Cells.  The preceding observations establish that endothelial 
cells express transcripts for Re1 family members and that levels 
of these transcripts can be modulated  by TNF-ol. Of the many 
induced genes at sites of endothelial activation which have 
KB sites, we have elected to further characterize  the KB site 
from the E-sdectin gene (4,  30) as an example of an NF- 
gB-dependent gene in endothelium. Nuclear extracts  were 
prepared and assayed for NF-KB binding activity using the 
EMSA. TNF-c~ specifically induced two NF-tcB--DNA bind- 
ing complexes in endothelial cells (Fig. 2 A, lanes 1 and 2). 
Competition of complexes A and B by unlabeled wild-type 
oligonudeotide,  but not by a mutant oligonucleotide, verified 
the specifically of binding to DNA (Fig.  2 A, lanes 3-6). 
A third complex (c) was constitutively expressed (Fig. 2 A, 
lane I) and was not competed by the highest concentration 
of unlabeled wild-type oligonucleotide, or by mutant NF- 
gB oligonudeotides (Fig. 2 A, lanes 3-6). Similar complexes 
Figure 2.  Activation of NF-xB in endothelial cells and the effects of 
antisera on NF-IcB  DNA binding. (A) Competition of DNA binding  by 
unlabeled wild-type (gB), but not mutant (taut)  oligonucleotides.  En- 
dotbelial cells were incubated in medium alone (lane 1) or TNF-o~ (200 
U/ml) for 1 h (lanes 2-6). Nuclear extracts were prepared and assayed 
for NF-~B binding activity in the absence or presence of indicated excess 
cold competitor  oligonudeotides.  (Arrows) Position of the induced com- 
plexes A and e, and the constitutive complex c. (/3) Reactivity of the in- 
duced xB binding  complexes with anti-p50, anti-p65, and anti-c-lkel an- 
tisera. Nuclear extracts from TNF-ot-treated  (200 U/ml, I h) endothelial 
cells were incubated with normal rabbit serum or antiserum before the 
assay for NILKB  binding  activity. Lane 1, no antisera; lane 2, normal rabbit 
serum (NRS); lane 3, anti-p50; lane 4, anti-p65; and lane 5, anti-c-Rel. 
in endothelial cells have been seen in response to LPS and 
with other sB sites (e.g.,  2,  3,  21). 
To determine which proteins were present in the E-selectin 
KB-DNA complexes induced by TNF-c~, human umbilical 
vein endothelial cell nudear extracts  were incubated with 2 
#1 of normal rabbit serum or antisera to p50, p65, and c-tel 
before the EMSA. As shown in Fig. 2 B, normal rabbit serum 
did not affect complex formation (lane 2). Anti-pS0 elimi- 
nated and/or caused a supershift in both induced complexes 
A and B (Fig. 2 B, lane 3). Anti-p65 caused a supershift of 
complex A, but did not affect formation of complex B (Fig. 
2 B, lane 4). Anti-c-Rel did not alter formation of either com- 
plex A or B (Fig.  2 B, lane 5), although this antibody did 
recognize c-Rel expressed by a human monocytic cell line 
(THP-1) (18) and in extracts of  Jurkat cells (data not shown) 
in a similar rB supershift analysis. None of the antisera affected 
formation of the nonspecific complex (c). Thus, the induced 
complexes contain p50 and p65 (complex a) and p50 (com- 
plex a)  NF-rB DNA-binding proteins, but not c-Rel. 
Biochemical characterization  of E-selectin KB binding pro- 
teins present in nuclear extracts of control and TNF-ot-treated 
human umbilical vein endothelial cells was accomplished by 
UV crosslinking analysis. A photoreactive form of the E-selec- 
tin KB probe was incubated with nuclear extracts from unin- 
duced and TNF-c~-treated endothelial cells. After UV irradi- 
ation,  the  resulting  protein-DNA  adducts  were  directly 
resolved by SDS-PAGE (Fig. 3 A) or immunopredpitated  with 
antisera to p50, p65, and c-Rel, and then resolved by SDS- 
PAGE (Fig. 3 B). TNF-c~ induced the formation of three major 
DNA protein adducts which migrated at 75 kD and as a 
50-55-kD doublet (Fig.  3 A, lane 4).  These adducts were 
specifically competed  with unlabeled wild-type oligonucleo- 
tide but not mutant oligonudeotide (Fig. 3 A, lanes 5 and 
6).  The molecular weights of these adducts are consistent 
with previously described p65 and p50 UV crosslinked  ad- 
ducts (25). Low levels of these adducts were observed in nu- 
clear extracts from uninduced  cells (Fig. 3 A, lanes 1-3). Im- 
munoprecipitation  analysis was used to identify these adducts. 
From TNF-c~-induced nuclear extracts,  anti-p65 identified 
a 75-kD adduct, corresponding to the predicted mobility of 
p65 covalently bound to the oligonucleotide (Fig. 3 A, lane 
7)  and  the  50-55-kD  adducts  (lane  7).  Anti-p50  coim- 
munoprecipitated a 75-kD adduct (p65) and two 50-55-kD 
adducts (Fig. 3 B, lane 6). Denaturation by heating in SDS 
before immunoprecipitation  confirmed that anti-p50 recog- 
nized only the 50-55-kD adducts, and that anti-p65 recog- 
nized only the 75-kD adduct (data not shown). Anti-c-Rel 
failed to immunoprecipitate  the expected 85-kD adduct, con- 
sistent with the lack of immunoreactivity by gel shift anal- 
ysis. From uninduced nuclear extracts,  p50 immunoprecipi- 
tated small amounts of 50-55-kD adducts (Fig. 3 B, lane 2). 
Cytoleine-induced Changes in IgB-~ and NF-r,B Protein Levels 
in Cultured Endothelial Cells.  To assess the dynamics of Ir.B-ee 
protein expression occurring during endothelial activation, 
human umbilical vein endothdial cells were treated with 
TNF-c~, and subcellnlar fractions were subjected to immu- 
noblotting (Fig. 4 A) and gel shift analysis (Fig. 4 B). Cyto- 
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vation by cytokine. Endothelial cells were stimulated with TNF-c~ (100 
U/ml).  (A) At the times indicated (lanes 2-9), cells were collected for 
the preparation of cellular extracts and cytosols analyzed for IxB-o~ by 
Western blot analysis. Lane I contains extract from COS cells which were 
transfected with exogenous IxB-ct. (/3) Nuclear extracts from cells treated 
as described  in A  were analyzed for NF-KB DNA binding activity. 
Figure 3.  UV crosslinking analysis of DNA protein complexes formed 
with the E-selectin KB site. (A) Nuclear extracts from uninduced (lanes 
I-3) and TNF-o~-treated (100 U/ml for 1 h, lanes 4-6) endothelial cells 
were incubated with a photoreactive form of the 32p-labded xB probe in 
the presence or absence of 50-fold unlabeled wild-type (r,B, lanes 2 and 
5) or mutant (MU, lanes 3 and 6) oligonucleotide. After UV irradiation, 
protein DNA adducts were analyzed on 8% SDS-PAGE. (B) Immunopre- 
cipitation of UV-crosslinked DNA protein complexes. Protein/DNA ad- 
ducts as described in A were immunoprecipitated with antiserum to p50 
(lanes 2 and 6), p65 (lanes 3 and 7), c-Rel (lanes 4 and 8), or normal rabbit 
serum (NRS, lanes I and 5). The resultant immune complexes were ana- 
lyzed on 8%  SDS-PAGE. 
solic extracts from cells  exposed to TNF-ot for the times shown 
in Fig. 4 A  (lanes 2-9) were analyzed by Western blotting 
using antisera raised to an IKB-o~  peptide (16, 19). A 37-kD 
protein was detected in cytoplasmic extracts from unstimu- 
lated cells (Fig. 4 A, lane 2) which comigrated with IxB-ot 
present in extracts from COS cells transfected with an exog- 
enous I~B-ot cDNA expression vector (Fig. 4 A, lane 1). In 
endothelial cells  treated with TNF-ot, cytoplasmic I~B-ot  com- 
pletely disappeared  within 15 mitt of stimulation. Ir,  B-cz gradu- 
ally reappeared in the cytoplasm (Fig. 4 A). IKB-ot did not 
accumulate in endothelial nudear extracts (data not shown). 
The time course of the depletion of IKB-ot after stimulation 
correlates with the nuclear appearance of NF-gB (Fig. 4 B). 
After 15 rain of TNF-ot exposure, NF-KB binding activity 
is present in endothelial nuclear extracts and IKB-ot  levels  have 
fallen dramatically (Fig. 4 B, lane 2). Although steady state 
levels of I~B-ot mRNA were dramatically  upregulated by 
TNF-c~ (Fig. 1 C), cytosolic IKB-cz  remained below baseline 
levels, perhaps indicating continuous degradation in response 
to cytokine.  Nuclear NF-KB binding remains elevated (Fig. 
4 B, lanes 6-8) for 24 h, consistent with the failure of cyto- 
solic IKB-cx  to return to baseline levels (Fig. 4 A, lanes 7-9). 
At this time, there is no transcription  from the E-selectin 
gene (4, and Fig. 1 A). Therefore, NF-xB cannot be entirely 
responsible for the temporally regulated pattern of cytoldne- 
induced E-selectin gene expression in endothelial cells. 
Immunoblotting analysis of the same nuclear and cyto- 
solic extracts revealed that the loss of IxB-ot in the cytoplasm 
correlated with the translocation  of p50 and p65 from the 
cytoplasm into the nucleus. Cultured endothelial cells have 
a substantial pool of both pS0 and p65 in a cytoplasmic re- 
serve (Fig. 5). Consistent with the UV-crosslinking analysis 
(Fig. 3 B, lane 2), p50 was present in small amounts in unin- 
duced nuclear extracts, whereas p65 and c-Rel were not de- 
tected (Fig. 5, lane 9). After 15 rain of TNF-c~ stimulation, 
both NF-gB components pS0 and p65 were markedly increased 
in the nucleus (Fig. 5, lane 10), consistent with the kinetics 
of induction of KB binding (Fig. 4 B), as well as the super- 
shift (Fig. 2 B) and UV crosslinking analyses (Fig. 3, A and 
B). Cytoplasmic pools of p50 and p65 were not depleted in 
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ponents.  After activation,  nuclear p50/p65 levels remained 
high despite the appearance of newly synthesized IgB-ot (Fig. 
5 A). The mechanism by which NF-~B persists in the nu- 
cleus with continued cytokine stimulation is unclear, c-Rel 
was seen in endothelial cells which comigrated with the c-Rel 
present in cytoplasmic extracts from Jurkat cells (Fig. 5, lane 
J).  Relative  to the amount of c-Rel found in comparable 
numbers of  Jurkat cells, the level of c-Rel in cytoplasmic ex- 
tracts of cultured human endothelial cells was low. In striking 
contrast to the results with pS0 and p65, c-Rel was not de- 
tected in the nucleus with cytokine stimulation. Thus, in en- 
dothelial cells, various Rel related proteins  can coexist and 
respond independently to environmental signals. 
A 
Regulation of  E-selectin Gene Expression by Recombinant  NF-r,B 
Components.  These findings establish that p50 and p65 rap- 
idly translocate into the nucleus of TNF-o~-treated endothelial 
cells and are capable of  binding to the E-selectin gB site. These 
observations,  however,  do  not  establish  the  functional 
significance  of these NF-KB  components in the transcriptional 
regulation of the E-sdectin gene. Previous deletion analysis 
in endothelial cells revealed that the JoB site in the E-sdectin 
core promoter was  necessary (but  not  sufl~dent)  for  the 
cytokine responsiveness of the gene (4). The NF-~B motif 
in the E-sdectin promoter (GGGGATTTCC) is completely 
conserved  in  both  the  human  (30) and  the  rabbit  (36) 
promoters and is in agreement with a consensus sequence 
(GGRNTTTCC)  for p65 binding (37).  Little variation  is 
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Figure  5.  SubceUular  location of 
NF-gB/R_d proteins in endothelial 
cells. Cytosolic (lanes I-8) and nu- 
clear (lanes 9-16) fractions prepared 
as in Fig. 4 were immunoblotted 
with antisera to p50, p65, and c-Rel. 
Lane J  is  cytosolic extract  from 
PMA-treated Jurkat  ceils.  (Right) 
Molecuhr weight markers. 
pOGH  pGH(-578)  pGH(-578)AkB  1  Z  3  4  5  6  7  8  9  1 0  1 1 
Figure 6.  Regulation of E-selectin gene expression by NF-KB and lxB-~v. (A) E-select'in gene expression induced by NF-xB components. Human 
umbilical vein endothelial cells were cotransfected with 1/~g of the NF-r,B component expression vectors, 20 ~tg of an E-sdectin-GH reporter plasmid, 
and 5/~g of pCATcontrol vector.  Transfection  dliciencies were normalized by measuring CAT activity.  (B) IgB-ot-mediated inhibition of E-selectin 
gene expression  induced by recombinant p65 or TNF-ot. BAEC were cotransfected  with 10/zg of an E-selectin-GH reporter plasmid, 10/~g le,  B-ot 
expression  vector,  and 2.5/~g of the control plasmid. Reporter construct activity is expressed as ng/ml growth hormone (GH), divided by cpm of 
CAT activity. The value of control pOGH is then set to 1.0. 
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terestingly, in the mouse E-selectin gene, only the 3' half site 
of the functional NF-xB promoter dement is conserved (38). 
The structure of the E-selectin NF-KB site suggests that the 
p65 component of NF-gB could play an important role in 
the induced expression of the E-selectin  gene. 
The potential function of the KB site in the E-selectin gene 
was analyzed by cotransfection experiments with an E-selectin 
promoter reporter construct and various NF-KB expression 
constructs, p65, or mixtures of p50 and p65, stimulated ex- 
pression of the chimeric reporter gene. The responsiveness 
of the E-sdectin promoter to stimulation was dependent upon 
the KB regulatory dement. Responses were similar in either 
human umbilical vein endothelial cells (Fig. 6 A), or BAEC 
(data not shown). Similar results were obtained with p65 ex- 
pression constructs and a VCAM-1 promoter-reporter con- 
struct (39). These results are consistent with the finding of 
r.B binding proteins observed in nuclear extracts from cytokine- 
stimulated endothelial cells and suggest that p65, either alone 
or in combination with p50, can induce expression of at least 
two NF-KB-dependent genes in endothelial cells. 
Ir,  B-~ Inhibits  F65 and TNF~-stimulated E-Selectin-Reporter 
Gene.  To determine whether induced E-selectin  gene ex- 
pression by NF-KB could be regulated by IgB-c~, expression 
vectors for different NF-gB subunits were cotransfected with 
an expression vector for IgS-c~ and an E-selectin-reporter gene_ 
With an E-selectin-GH reporter, transfection of I~B-c~ al- 
most completely abolished marker gene expression stimulated 
by p65 in bovine endothelial cells (Fig. 6 B, lanes 7 and 8), 
as well as in human umbilical vein endothelial cells and COS 
cells (data not shown). These findings demonstrate that the 
transcriptional activation of the E-sdectin gene induced by 
NF-KB can be regulated by IsB-c~. Similar results were ob- 
tained with p65, IxB-c~, and a VCAM-1 promoter-reporter 
construct (39), raising the possibility that IgB-c~ may regu- 
late expression of multiple NF-KB-dependent genes in en- 
dothdial cells. 
These findings are consistent with the inhibition of p65- 
mediated transcription by transfected IKB-c~ reported earlier 
with other cell types and different reporter genes (e.g.,  16, 
17). To extend these observations, we determined whether 
IxB-a could block E-sdectin reporter gene expression induced 
by TNF-ol in endothelial cells (Pig. 6 B). Endothelial cells 
were transfected with an E-sdectin-GH reporter, the IsB-cz 
expression vector, and then challenged with human TNF-cz. 
Transfection of the  I~B-a  expression vector blocked the 
TNF-a-induced expression of the E-selectin reporter gene 
(Fig. 6 B, lanes 5 and 6). Suppression of the E-sdectin-GH 
expression by IKB-a was dose dependent (data not shown). 
In contrast, a constitutively expressed reporter gene (thymi- 
dine kinase-growth hormone, pTKGH), was not affected by 
expression of IsB-a (Fig. 6 B, lanes 9-11), suggesting that 
the suppressive effect was specific for genes that are depen- 
dent upon NF-xB. These studies demonstrate that IgB-a can 
suppress TNF-a-induced expression of an E-selectin reporter 
gene in cultured endothelial cells. 
Discussion 
These studies demonstrate that human endothelial cells ex- 
press multiple members of the Rel family transcription factors, 
and that stimulation by TNF-c~ results in translocation of 
p50 and p65 to the nucleus. The functional significance of 
two of these factors in endothelial gene regulation was demon- 
strated by transient transfection analysis, where cotransfec- 
tion of p65 or p65/p50 resulted in increased levets of expres- 
sion of an E-selectin-reporter  construct. Endothelial cells also 
express an inhibitor of NF,-xB activation, Ir~B-c~, and can dra- 
maticaUy modulate the level of this inhibitor in paralld with 
the  activation  process.  IxB-c~ is  functionally relevant  in 
cytokine-induced  expression of E-sdectin, in that overexpres- 
sion of this protein in endothelial cells blocks TNF-c~ and 
p65-mediated expression of an E-sdectin promoter-reporter 
gene. These data suggest that NF-KB and IKB-c~ are involved 
in cytokine~mediated signaling and may play an important 
role in regnhtion of gene expression during endothelial acti- 
vation. 
Regnlation of the NF-xB/IxB-c~ system in endothelial cells 
may be a tightly controlled process that ensures that the en- 
dothelium can make appropriate responses to environmental 
stimuli. The presence of cytoplasmic pools of p50 and p65 
in endothelial cells suggests that the cells are primed for acti- 
vation. If endothdial cells arc similar to other cell types, the 
NF-KB heterodimers are maintained in the endothelial cyto- 
plasm by IxB-c~ (for reviews see references 12-15).  Here we 
demonstrate that activation-induced IgB-c~ degradation in en- 
dothelial cells is coupled to NF-gB nuclear translocation. 
Specific signals, such as cytokines or LPS, release p50/p65 
from the Ir,  B-c~, resulting in rapid translocation of transcrip- 
tionally active heterodirners to the endothelial nucleus. The 
exact signal transduction pathways for activating NP-~B in 
endothelial  calls  are  not  understood,  although TNF-c~- 
induced cell adhesion to human endothdial ceils is mediated 
through the 55-kD TNF-c~ receptor (40). In other cell types, 
TNF-c~ has been shown to activate NF-xB through genera- 
tion of ceramide, which is released fi:om sphingomyelin by 
enzymatic hydrolysis (41). Other Rd-related factors in en- 
dothdial cells, specifically, c-Rel, may be activated by dis- 
tinct, as yet undefined stimuli. 
The full complement of physiologically relevant target genes 
for NF-KB in endothelial cells is not dear. The nature of the 
responsive target genes probably depends upon the activa- 
tion of specific Rel-related protein complexes and the struc- 
ture of the r,B sites (37). Here we demonstrate that pS0/p65 
act on the E-sdectin promoter, and in parallel studies sug- 
gest that the VCAM-1 gB sites are also a target of NF-KB 
activation (39). Additionally, we show here that the genes 
that code for p65, p105, and IxB-c~ are highly inducible in 
endothelial cells in response to the stimuli that activate NF- 
gB. These results are consistent with recent observations that 
the promoter of the IKB-c~ gene contains xB binding sites 
(42) and that p65 stimulates IKB-ce gene expression (42-45). 
Thus p65 and IgB~ have been directly linked in an auto~mla- 
tory loop. Additionally, p65 stabilizes IgB-c~  protein (43, 45), 
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itor. The significance of the autoregulatory loop for NF-JcB 
and hoB-or is that it allows a continuous maintenance of the 
cytoplasmic reservoirs of NK-~B complexes for stimulation 
in an acute response,  and also prepares the endothdial  cell 
to return  NF-KB to its uninduced condition. 
The NF-~B and IKB-ot mechanism insures that the induc- 
tion of NF-KB is transient and that the activated endothelial 
cell returns to a quiescent state within a relatively short period. 
The rapid cytokine-induced activation of NF-gB in endothelial 
cells is probably similar to that seen in other cell types; how- 
ever, the recovery kinetics of the NF-gB/IgB-ot response in 
endotbelium may be different. The data presented here sug- 
gest that NF-~B remains activated and I~cB-c~ levels remain 
below basal levels for longer periods of time than seen in cells 
programmed for rapid responses, such as macrophages.  It is 
possible that cytokines released by activated endothdial cells 
result in an autocrine activation of NF-r,B and continued degra- 
dation of IrB-o~. Such prolonged endothelial activation may 
play a role in recruiting circulating cells to sites of ongoing 
inflammatory  or immune  processes. 
The regulation of NF-JcB activation may be important in 
the initial onset of multiple forms of vascular pathobiology. 
Situated between the circulating blood elements and the sur- 
rounding tissues, vascular endothelium is in a privileged ana- 
tomic setting. Endothdial cells at sites of inflammatory re- 
sponses are exposed to activating cytokines and various forms 
of reactive oxygen SlX'des. Many of these agents may have 
in common the ability to generate oxidant stress and activate 
NF-KB (46).  Since multiple  genes relevant to the pathobi- 
ology of endothelial  activation  have potentially functional 
NF-~cB sites,  activation of the pldotropic mediator  NF-gB 
in  endothelial  cells  could  coordinate  the  expression  of 
numerous endothelial products which are important  in en- 
dothelial activation, including some cell surface adhesion pro- 
reins, cytokines, growth factors, and components of the coagu- 
lation  system.  These  endothelial  cell  products  may  act 
cooperatively to facilitate inflammatory or immune responses. 
Increased expression of inhibitors of NF-gB activation might 
decrease NF-KB activation and diminish expression of NF- 
gB-dependent genes. This regulatory mechanism insures that 
the induction of NF-tcB is transient  and that  the activated 
endothelial cell returns  to a quiescent  state.  This dynamic 
balance might be offset during the initial onset of vascular 
pathology, such as in the initiation of the atherosclerotic le- 
sion (47). 
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